Table 3.
Characteristics of M. genitalium strains in follow-up samples.
| M. genitalium-Positive Follow-Up Samples (Belonging to Patient No. in Table 1, Previous Follow-Up Sample No.) | Weeks after Previous Test | Previous Antibiotic Treatment | Negative Test between First and Follow-Up Sample | MRAM | FRAM | TRAM | Genotype |
|---|---|---|---|---|---|---|---|
| 1f (2) | 18 | MOX 1 | yes | no | no | no | 2–14 |
| 2f (15) | 8 | DOX 2 | no | A2059G | no | n.d. | 4–11 |
| 3f (13) | 12 | no | no | no | no | 3–8 | |
| 4f (19) | 26 | no | A2058G | D87Y | C1192G | 113–11 | |
| 5f (26) | 15 | no | A2059G | no | no | 4–10 | |
| 6f (29) | 13 | DOX | no | A2059G | no | no | 4–12 |
| 7f (5) | 52 | MOX | yes | no | no | n.d. | 4–11 |
| 8f (15, 3f) | 34 | no | A2059G | no | no | 4–n.d. | |
| 9f (26, 6f) | 12 | no | A2059G | no | no | 4–10 | |
| 10f (7) | 59 | yes | A2059G | no | no | 4–10 | |
| 11f (19, 5f) | 26 | no | A2058G | D87Y | C1192G | 113–11 | |
| 12f (26, 6f, 10f) | 17 | no | A2059G | no | no | 4–10 | |
| 13f (26, 6f, 10f, 13f) | 9 | no | A2059G | no | no | 4–10 | |
| 14f (48) | 27 | no | A2059G | no | no | 4–9 | |
| 15f (24) | 59 | no | A2058G | S83I | G966T and G967T | 3–13 | |
| 16f (12) | 85 | no | A2059G | no | no | 4–10 |
1—moxifloxacin; 2—doxycycline.